Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Information Request Email, May 13, 2013 - Novoeight

From: Pracht, Leigh

Sent: Monday, May 13, 2013 2:20 PM

To: LEWP (Lewis Pollack)

Subject: STN 125466/0: Information Request 13-May-13

Our Reference: BL 125466/0

Novo Nordisk Inc.

Attention: Lewis Pollack, PhD

May 13, 2013

Sent by email

Dear Dr. Pollack:

We are reviewing your October 15, 2012 biologics license application (BLA) for Antihemophilic Factor (Recombinant), Plasma/Albumin Free [NovoEight]. We determined that the following information is necessary to continue our review:

1. CBER requires the following reagents and samples to complete in-support testing:

2 vials of control ---(b)(4)---

2 vials of each: ------(b)(4)----------- and ---(b)(4)---

Please send them to:

Karen Campbell


Building B Room 2410

5516 Nicholson Lane

Kensington, MD 20895

The review of this submission is on-going and issues may be added, expanded upon, or modified as we continue to review this submission.

Please provide shipping information, as a written amendment to this file, by May 27, 2013 referencing the date of this request. If you anticipate you will not be able to respond by this date, please contact the Agency immediately so a new response date can be identified.

The action due date for this file is October 15, 2013.

If you have any questions, please contact me at (301) 827-6116.


Leigh A. Pracht

Regulatory Project Manager


WOC1; RM562N; HFM-380

1401 Rockville Pike

Rockville, MD 20852

Telephone: 301-827-6116

Fax: 301- 827-2857

THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in error, please immediately notify the sender by e-mail or phone.

Page Last Updated: 03/24/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.